170 results
Page 3 of 9
8-K
EX-99.1
pcvqywggt9w j4a
14 Jan 14
Cell Therapeutics Announces 2014 Outlook and Recent Drug Portfolio Progress
12:00am
8-K
EX-99.1
daem45nv857qm
6 Jan 14
PIXUVRI® (pixantrone) Receives Positive Final Appraisal Determination from NICE
12:00am
8-K
EX-99.1
xdpire7z
2 Jan 14
Cell Therapeutics Announces Removal of the Partial Clinical Hold on Tosedostat
12:00am
8-K
EX-99.1
njrt vjzb
7 Mar 12
Cell Therapeutics, Inc. (CTI) Reports Fourth Quarter and Year-End Financial Results and Milestones
12:00am
424B5
yg5va lmjk3qg
9 Dec 11
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
7zvngmlzti5h
25 Oct 11
Cell Therapeutics, Inc. (CTI) Reports Third Quarter Financial Results and Milestones
12:00am
8-K
EX-99.1
aub vn2ymsq
28 Jul 11
FDA appeal guidance allows CTI to resubmit pixantrone NDA in 4th quarter with no new clinical trials in advance of potential accelerated approval
12:00am
8-K
EX-99.1
1kncfk8
14 Mar 11
Phase III Pivotal Trial in Acute Myeloid Leukemia Expected to Start in Q4 2011
12:00am